Check out which companies are making headlines before the bell:
General Electric—The industrial conglomerate reported quarterly profit of 56 cents per share, beating estimates by a penny. Revenue was slightly shy of consensus, as falling orders in the oil and gas segment pressured results.
McDonald's—The fast-food giant fourth-quarter earnings and revenue missed estimates. McDonald's reported earnings of $1.13 per share, on revenue of $6.57 billion. Wall Street expected earnings of $1.22 a share on $6.68 billion in revenue.
State Street—State Street earned an adjusted $1.37 per share for the fourth quarter, beating estimates by 11 cents, with revenue also above estimates. The investment firm's results were powered by its trading services and foreign exchange segments.
Bank of NY Mellon—The bank fell 1 cent short of estimates with adjusted fourth quarter profit of 58 cents per share, with revenue also fell below estimates. The bottom line was hurt by losses in fixed income and a drop in net interest income. The company did see stronger revenue from currency trading.
Starbucks—The coffee chain matched estimates with adjusted quarterly profit of 80 cents per share, with revenue also in line. Starbucks did give current quarter guidance below Street estimates, but it also gave an upbeat assessment of customer traffic in its Americas region locations.
United Technologies—Citi began coverage of the stock with a "buy" rating. Among other factors, Citi thinks United Technologies is poised to benefit from trends that will drive demand for its building products.
Capital One—The credit card issuer fell 8 cents shy of estimates with adjusted quarterly profit of $1.68 per share, though revenue was above estimates. Capital One set aside more money during the quarter to cover bad loans.
Lululemon—JPMorgan Chase upgraded the yoga wear maker's shares to "overweight" from "neutral," saying the building blocks are in place for a $4 billion brand five years from now compared to about $1.8 billion now.
Kimberly-Clark—The consumer products company earned an adjusted $1.43 per share for its latest quarter, 6 cents above estimates, though revenue was slightly short of consensus.
DreamWorks Animation—The movie studio is cutting 500 jobs as part of a restructuring, which will see it cut the number of films it produces each year to two from three. Following the news of the restructuring, Piper Jaffray upgraded the stock to "overweight" from "neutral."
E*Trade Financial—The discount brokerage earned an adjusted 26 cents per share for its latest quarter, 3 cents above estimates, and saw revenue beat analyst forecasts as well. The discount brokerage did see profit fall almost 30 percent from the prior year as it booked losses related to retiring corporate debt.
Intuitive Surgical—The maker of surgical products earned $4.92 per share for its latest quarter, beating estimates of $4.38. Revenue was also above consensus, but Intuitive Surgical also said it expected a stronger dollar to hurt current quarter results. The company did see an increase in the number of procedures performed with its da Vinci robotic surgical system.
Apple—Apple will have an opening on its board of directors, with J. Crew CEO Mickey Drexler informing the company he will not run for re-election when his term expires in March.
LeapFrog—The toy maker issued preliminary results for the quarter that ended December 31, saying its sales fell "significantly below" expectations and that it would not achieve its full fiscal year guidance. LeapFrog points to declines in sales of children's tablets and a later than expected shipment of its LeapTV educational video game system, among other factors.
Box—The online data storage company will begin trading today after pricing its initial public offering at $14 per share, above the expected $11 - $13 range. The pricing values Box at about $1.67 billion.
Sony—The company will delay its third quarter earnings report, stemming from the massive hacking attack on its Sony Pictures Entertainment unit.
Novo Nordisk—The drug company expects to launch its obesity treatment Saxenda in Europe this year, following a positive opinion from authorities. The Danish company said final approval should come within two to three months.